Total Payments
$24,522
2023 Payments
$4,543
Companies
11
Transactions
110
Medicare Patients
2,153
Medicare Billing
$272,763
Payment Breakdown by Category
Other$20,043 (81.7%)
Food & Beverage$2,054 (8.4%)
Travel$1,332 (5.4%)
Research$1,094 (4.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20,043 | 5 | 81.7% |
| Food and Beverage | $2,054 | 85 | 8.4% |
| Travel and Lodging | $1,332 | 13 | 5.4% |
| Unspecified | $1,094 | 7 | 4.5% |
Payments by Type
General
$23,428
103 transactions
Research
$1,094
7 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Mallinckrodt Hospital Products Inc. | $11,728 | 13 | $0 (2023) |
| ABBVIE INC. | $10,981 | 52 | $0 (2023) |
| Gilead Sciences, Inc. | $1,293 | 16 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $143.54 | 8 | $0 (2023) |
| INTERCEPT PHARMACEUTICALS, INC. | $143.01 | 8 | $0 (2022) |
| Shionogi Inc | $94.18 | 5 | $0 (2019) |
| Dynavax Technologies Corporation | $51.73 | 4 | $0 (2022) |
| VBI Vaccines (Delaware) Inc. | $28.35 | 1 | $0 (2022) |
| Medtronic, Inc. | $23.63 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $23.23 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $4,543 | 15 | Mallinckrodt Hospital Products Inc. ($4,348) |
| 2022 | $18,059 | 46 | ABBVIE INC. ($10,509) |
| 2021 | $180.15 | 9 | AbbVie Inc. ($63.28) |
| 2020 | $107.65 | 6 | AbbVie Inc. ($72.53) |
| 2019 | $1,513 | 28 | Gilead Sciences, Inc. ($1,151) |
| 2018 | $118.76 | 6 | Gilead Sciences, Inc. ($44.26) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/18/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: VIROLOGY | ||||||
| 06/22/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: VIROLOGY | ||||||
| 06/22/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: VIROLOGY | ||||||
| 05/10/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $27.54 | General |
| Category: VIROLOGY | ||||||
| 04/27/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $27.76 | General |
| Category: VIROLOGY | ||||||
| 04/13/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $8.03 | General |
| Category: VIROLOGY | ||||||
| 04/11/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: VIROLOGY | ||||||
| 03/29/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: VIROLOGY | ||||||
| 03/28/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: VIROLOGY | ||||||
| 02/22/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: VIROLOGY | ||||||
| 02/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Gastroenterology | ||||||
| 01/25/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $35.18 | General |
| Category: CRITICAL CARE | ||||||
| 01/19/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Travel and Lodging | Cash or cash equivalent | $66.25 | General |
| Category: CRITICAL CARE | ||||||
| 01/19/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Travel and Lodging | Cash or cash equivalent | $6.82 | General |
| Category: CRITICAL CARE | ||||||
| 01/05/2023 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,240.00 | General |
| Category: CRITICAL CARE | ||||||
| 12/27/2022 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Travel and Lodging | Cash or cash equivalent | $36.25 | General |
| Category: CRITICAL CARE | ||||||
| 12/27/2022 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Travel and Lodging | Cash or cash equivalent | $9.94 | General |
| Category: CRITICAL CARE | ||||||
| 12/14/2022 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $31.05 | General |
| Category: CRITICAL CARE | ||||||
| 12/13/2022 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,890.00 | General |
| Category: CRITICAL CARE | ||||||
| 12/13/2022 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $123.97 | General |
| Category: CRITICAL CARE | ||||||
| 12/07/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Gastroenterology | ||||||
| 12/03/2022 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $55.00 | General |
| Category: CRITICAL CARE | ||||||
| 12/03/2022 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $39.99 | General |
| Category: CRITICAL CARE | ||||||
| 12/02/2022 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Travel and Lodging | In-kind items and services | $158.96 | General |
| Category: CRITICAL CARE | ||||||
| 11/29/2022 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Hepatology / Gastroenterology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety, Tolerability, and Efficacy of Cilofexor in Non-Cirrhotic Subjects with Primary Sclerosing Cholangitis | Gilead Sciences, Inc. | $1,094 | 7 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 556 | 636 | $415,522 | $56,820 |
| 2022 | 10 | 463 | 752 | $166,085 | $59,390 |
| 2021 | 12 | 570 | 920 | $179,054 | $75,118 |
| 2020 | 13 | 564 | 954 | $202,249 | $81,435 |
Total Patients
2,153
Total Services
3,262
Medicare Billing
$272,763
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 160 | $46,802 | $13,719 | 29.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 39 | 39 | $61,685 | $7,845 | 12.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 51 | 51 | $76,793 | $5,970 | 7.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 74 | $14,149 | $4,504 | 31.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 62 | 62 | $86,884 | $3,802 | 4.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 21 | 21 | $25,583 | $3,505 | 13.7% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2023 | 48 | 49 | $18,297 | $3,317 | 18.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 17 | 17 | $20,945 | $2,995 | 14.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 22 | $11,428 | $2,789 | 24.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $9,579 | $2,481 | 25.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 22 | 23 | $8,553 | $2,236 | 26.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $14,344 | $1,663 | 11.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 13 | 13 | $19,358 | $1,441 | 7.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 52 | 66 | $1,122 | $554.40 | 49.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 278 | $51,558 | $24,310 | 47.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 50 | 194 | $39,439 | $15,107 | 38.3% |
| 76981 | Ultrasound scan of organ tissue for measuring elasticity | Office | 2022 | 100 | 101 | $31,447 | $7,455 | 23.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 25 | 30 | $7,641 | $3,098 | 40.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 28 | 28 | $8,165 | $3,015 | 36.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 11 | 14 | $5,625 | $2,121 | 37.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 20 | 21 | $15,176 | $1,754 | 11.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 19 | 30 | $4,660 | $1,631 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 14 | $1,660 | $775.15 | 46.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 40 | 42 | $714.00 | $124.41 | 17.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 79 | 256 | $40,960 | $20,778 | 50.7% |
About Dr. Hussien Elsiesy, MD
Dr. Hussien Elsiesy, MD is a Gastroenterology healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265450811.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hussien Elsiesy, MD has received a total of $24,522 in payments from pharmaceutical and medical device companies, with $4,543 received in 2023. These payments were reported across 110 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($20,043).
As a Medicare-enrolled provider, Elsiesy has provided services to 2,153 Medicare beneficiaries, totaling 3,262 services with total Medicare billing of $272,763. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology, Gastroenterology
- Location Dallas, TX
- Active Since 07/18/2006
- Last Updated 11/13/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1265450811
Products in Payments
- TERLIVAZ (Drug) $11,693
- MAVYRET (Drug) $10,820
- XIFAXAN (Drug) $143.54
- OCALIVA (Drug) $143.01
- Mavyret (Drug) $136.32
- Mulpleta (Drug) $94.18
- Heplisav-B (Drug) $51.73
- PreHevbrio (Drug) $28.35
- Viekira Pak (Drug) $23.97
- ENDOFLIP (Device) $23.63
- Kanuma (Drug) $23.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Dallas
Dr. Michael Brown, Md, MD
Gastroenterology — Payments: $6.0M
Gastroenterology $6.0M
Jay Horton, Md, MD
Gastroenterology — Payments: $419,727
Gastroenterology $419,727
Dr. Lawrence Schiller, Md, MD
Gastroenterology — Payments: $380,832
Gastroenterology $380,832
Dr. Jacqueline O'leary, Md, Mph, MD, MPH
Gastroenterology — Payments: $338,210
Gastroenterology $338,210
Dr. Byron Cryer, M.d, M.D
Gastroenterology — Payments: $331,404
Gastroenterology $331,404
Dr. Sami Arslanlar, Md, MD
Gastroenterology — Payments: $144,674
Gastroenterology $144,674